Join to View Full Profile
600 Highland AveMadison, WI 53792
Phone+1 608-265-1700
Fax+1 608-266-6020
Dr. Pophali is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified hematologist and medical oncologist specializing in managing lymphomas and CLL. My research focus is survivorship and health outcomes.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2018 - 2019- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2015 - 2018
Cleveland Clinic FoundationResidency, Internal Medicine, 2012 - 2015
Indira Gandhi Medical CollegeClass of 2010, MBBS, Best Medical Student in the State of Maharashtra
Certifications & Licensure
WI State Medical License 2019 - 2025
MN State Medical License 2015 - 2020
OH State Medical License 2012 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
American Board of Medical SpecialtiesHematology- American Board of Medical SpecialtiesMedical Oncology
Clinical Trials
- Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia Start of enrollment: 2022 Jun 01
Roles: Contact
Publications & Presentations
PubMed
- Measurable Residual Disease Testing Following Nonintensive Chemoimmunotherapy is Predictive of Need for Maintenance Therapy in Previously Untreated Mantle Cell Lymphom...Julie E Chang, Danielle McQuinn, Meredith Hyun, KyungMann Kim, Vaishalee P Kenkre
Clinical Lymphoma, Myeloma & Leukemia. 2025-03-01 - 4 citationsCD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphoma.Priyanka A Pophali, Joshua A Fein, Kwang W Ahn, Molly Allbee-Johnson, Nausheen Ahmed
Blood Advances. 2024-10-22 - 1 citationsAnti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed or refractory large B-cell lymphoma: A multicenter study.Aung M Tun, Romil D Patel, Frederique St-Pierre, Evguenia Ouchveridze, Alex Niu
American Journal of Hematology. 2024-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
